Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 84.55% | 91.73% | 98.10% | 47.13% | -2.26% |
| Total Revenue | 84.55% | 91.73% | 98.10% | 47.13% | -2.26% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 84.55% | 91.73% | 98.10% | 47.13% | -2.26% |
| SG&A Expenses | 4.07% | 6.32% | 7.29% | 13.01% | 20.76% |
| Depreciation & Amortization | -2.86% | -0.66% | 0.15% | -0.76% | -0.82% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.14% | 16.76% | 42.28% | 30.57% | 20.03% |
| Operating Income | 34.07% | 11.45% | -17.35% | -23.33% | -29.57% |
| Income Before Tax | 34.84% | 11.65% | -17.99% | -22.84% | -27.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.84% | 11.65% | -17.99% | -22.84% | -27.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.84% | 11.65% | -17.99% | -22.84% | -27.89% |
| EBIT | 34.07% | 11.45% | -17.35% | -23.33% | -29.57% |
| EBITDA | 34.76% | 11.72% | -17.87% | -24.04% | -30.44% |
| EPS Basic | 54.17% | 27.91% | -2.56% | -10.00% | -14.29% |
| Normalized Basic EPS | 53.33% | 29.63% | 4.00% | -3.85% | -11.11% |
| EPS Diluted | 54.17% | 27.91% | -2.56% | -10.00% | -14.29% |
| Normalized Diluted EPS | 53.33% | 29.63% | 4.00% | -3.85% | -11.11% |
| Average Basic Shares Outstanding | 35.04% | 28.11% | 20.69% | 13.97% | 7.23% |
| Average Diluted Shares Outstanding | 35.04% | 28.11% | 20.69% | 13.97% | 7.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |